Kinetics of phenylalanine transport at the human blood-brain barrier investigated in vivo

Brain Research

Volumn 778, Issue 2, 1997, Pages 329-337

  Möller, Harald E ^a,b   Weglage, Josef ^b   Wiedermann, Dirk ^b   Vermathen, Peter ^c   Bick, Ulrich ^b   Ullrich, Kurt ^d  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Blood brain barrier; Difference spectroscopy; Hyperphenylalaninemia; Michaelis Menten kinetics; Phenylalanine transport; Phenylketonuria; Proton magnetic resonance spectroscopy; Saturation kinetics

Indexed keywords

PHENYLALANINE;

ADULT; AMINO ACID TRANSPORT; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERPHENYLALANINEMIA; MALE; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSPORT KINETICS;

ADOLESCENT; ADULT; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; CHILD; FEMALE; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHENYLALANINE; PHENYLKETONURIAS;

EID: 0031578881     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01054-8     Document Type: Article

References (38)

1. Avison M.J., Herschkowitz N., Novotny E.J., Petroff O.A.C., Rothman D.L., Colombo J.P., Bachmann C., Shulman R.G., Prichard J.W. Proton NMR observation of phenylalanine and an aromatic metabolite in the rabbit brain in vivo. Pediatr. Res. 27:1990;566-570.
2. Bick U., Ullrich K., Stöber U., Möller H., Schuierer G., Ludolph A.C., Oberwittler C., Weglage J., Wendel U. White matter abnormalities in patients with treated hyperphenylalaninemia: Magnetic resonance relaxometry and proton spectroscopy findings. Eur. J. Pediatr. 152:1993;1012-1020.
3. Blascovics M.E., Scheffler G.E., Hacks S. Phenylalaninemia. Differential diagnosis. Arch. Dis. Child. 49:1974;835-843.
4. Choi T.B., Pardridge W.M. Phenylalanine transport at the human blood-brain barrier. J. Biol. Chem. 261:1986;6536-6541.
5. Clarke J.T., Gates R.T., Hogan S.E., Barrett M., MacDonald G.W. Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets. Am. J. Ment. Retard. 92:1987;255-262.
6. Cleary M.A., Walter J.H., Wraith J.E., Jenkins J.P., Alani S.M., Tyler K., Whittle D. Magnetic resonance imaging of the brain in phenylketonuria. Lancet. 344:1994;87-90.
7. Frahm J., Michaelis T., Merboldt K.D., Bruhn H., Gyngell M.L., Hänicke W. Improvements in localized proton NMR spectroscopy of human brain. Water suppression, short echo times, and 1 ml resolution. J. Magn. Reson. 90:1990;464-473.
8. 13C nuclear magnetic resonance. Adv. Exp. Med. Biol. 331:1993;35-40.
9. 1H NMR studies of glucose transport in the human brain. J. Cereb. Blood Flow Metab. 16:1996;427-438.
10. Hájek M., Hejcmanová, Prádny L. Proton in vivo spectroscopy of patients with hyperphenylalaninemia. Neuropediatrics. 24:1993;111-112.
11. Holtzman N.A., Kronmal R.A., van Doorninck W., Azen C., Koch R. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria. New Engl. J. Med. 314:1986;593-598.
12. Hommes F.A. The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninemia. J. Inher. Met. Dis. 12:1989;41-46.
13. Hommes F.A., Lee J.S. The control of 5-hydroxytryptamine and dopamine synthesis in the brain: a theoretical approach. J. Inher. Metab. Dis. 13:1990;37-57.
14. Johannik K., Van Hecke P., Francois B., Marchal G., Smet M.H., Jaecken J., Breysem L., Wilms G., Baert A.L. Localized brain proton NMR spectroscopy in young adult phenylketonuria patients. Magn. Reson. Med. 31:1994;53-57.
15. Knudsen G.M., Hasselbalch S., Toft P.B., Christensen E., Paulson O.B., Lou H. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria. J. Inher. Metab. Dis. 18:1995;653-664.
16. Krause W., Halminski M., McDonald L., Dembure P., Salvo R. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man. J. Clin. Invest. 75:1985;40-48.
17. 1H magnetic-resonance spectroscopy. J. Magn. Reson. B 107:1995;242-251.
18. Lou H.C., Güttler F., Lykkelund C., Niederwieser A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment of phenylketonuria in adolescents. Eur. J. Pediatr. 144:1985;17-29.
19. Lund-Andersen H. Transport of glucose from blood to brain. Physiol. Rev. 59:1979;305-352.
20. 13C nuclear magnetic resonance spectroscopy. Adv. Exp. Med. Biol. 331:1993;29-34.
21. McKean C.M. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain. Brain Res. 47:1972;469-476.
22. Möller H.E., Bick U., Stöber U., Vermathen P., Ullrich K. Metabolic findings in patients with treated hyperphenylalaninemia with in vivo proton MR spectroscopy. J. Magn. Reson. Imag. 3 P:1993;160-161.
23. Möller H.E., Vermathen P., Ullrich K., Weglage J., Koch H.G., Peters P.E. In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment. Neuropediatrics. 26:1995;1-4.
24. 1H MRS study. In: Proc. of the Int. Soc. of Magn. Resonance in Med., 5th Sci. Meet. and Exh., Vancouver, 1997, p. 1208.
25. Momma S., Aoyagi M., Rapoport S.I., Smith Q.R. Phenylalanine transport across the blood-brain barrier as studied with the in situ brain perfusion technique. J. Neurochem. 48:1987;1291-1300.
26. Novotny E.J., Avison M.J., Herschkowitz N., Petroff O.A.C., Prichard J.W., Seashore M.R., Rothman D.L. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy. Pediatr. Res. 37:1995;244-249.
27. Pardridge W.M., Oldendorf W.H. Kinetic analysis of blood-brain barrier transport of amino acids. Biochim. Biophys. Acta. 401:1975;128-136.
28. Pardridge W.M. Brain metabolism: a perspective from the blood-brain barrier. Physiol. Rev. 63:1983;1481-1535.
29. Perry T.L., Hansen S., Berry K., Mok C., Lesk D. Free amino acids and related compounds in biopsies of human brain. J. Neurochem. 18:1971;521-528.
30. 1H magnetic resonance spectroscopy. Pediatr. Res. 38:1995;657-663.
31. Pietz J., Kreis R., Schmidt H., Meyding-Lamadé U.K., Rupp A., Boesch C. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology. 201:1996;413-420.
32. C.R. Scriver, S. Kaufman, S.L.C. Woo, The hyperphenylalaninemias. In: C.R. Scriver, A.L. Baudet, W.S. Sly, D. Valle (Eds.), The Metabolic Basis of Inherited Disease I, McGraw-Hill, New York, 1989, pp. 495-496.
33. Smith I., Beasley M.G., Ades A.E. Intelligence and quality of dietary treatment in phenylketonuria. Arch. Dis. Child. 65:1990;472-478.
34. Smith Q.R., Momma S., Aoyogi M., Rapaport S.I. Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neurochem. 49:1987;1651-1658.
35. U. Tewes, Hamburg Wechsler Intelligenztest für Erwachsene Hamburg Wechsler - Revidiert (HAWIE-R), Verlag Hans Huber, Bern, 1983.
36. Ullrich K., Möller H., Weglage J., Schuierer G., Bick U., Ludolph A., Hahn-Ullrich H., Fünders B., Koch H.G. White matter abnormalities in phenylketonuria: results of magnetic resonance measurements. Acta Paediatr. Suppl. 407:1994;78-82.
37. D. Wechsler, Hamburg Wechsler Intelligenztest für Kinder - Revidiert (HAWIK-R), Verlag Hans Huber, Bern, 1991.
38. Weglage J., Pietsch M., Fünders B., Koch H.G., Ullrich K. Neurological findings in early treated phenylketonuria. Acta Paediatr. 84:1995;411-415.